Related Experiment Videos

Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein

J Tatzelt1, N Maeda, M Pekny

  • 1Department of Neurology, University of California, San Francisco 94143-0518, USA.

Neurology
|August 1, 1996
PubMed

Insights

This study investigated reactive gliosis in prion diseases. Findings show that apolipoprotein E (apoE) and glial fibrillary acidic protein (GFAP) do not influence prion disease progression or PrPSc production.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Prion diseases are characterized by reactive gliosis, an increase in glial cells, often disproportionate to neuronal damage.
  • Apolipoprotein E (apoE) and glial fibrillary acidic protein (GFAP) are upregulated in astrocytes during reactive gliosis in scrapie.

Purpose of the Study:

  • To investigate the role of astrocytic gliosis, specifically apoE and GFAP, in the pathogenesis of experimental scrapie in mice.
  • To determine if the absence of apoE or GFAP affects prion disease incubation times or PrPSc accumulation.

Main Methods:

  • Mice genetically modified to be deficient in either apolipoprotein E (apoE) or glial fibrillary acidic protein (GFAP) were inoculated with mouse prions.
  • Incubation times, clinical signs, and prion protein scrapie (PrPSc) levels and distribution in the brain were compared between knockout mice and control mice.

Main Results:

  • Mice deficient in apoE or GFAP exhibited incubation times for scrapie that were indistinguishable from those of control mice.
  • The levels and regional deposition of PrPSc in the brains of ill mice lacking apoE or GFAP were similar to those in control mice.

Conclusions:

  • Neither apolipoprotein E (apoE) nor glial fibrillary acidic protein (GFAP) plays a significant role in the pathogenesis of experimental prion disease (scrapie).
  • These proteins are not essential for the production or propagation of the disease-associated prion protein, PrPSc.

Related Concept Videos